Iwamoto T, Uemura Y, Ishikawa T, Jo A, et al. Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 - metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study. Breast Cancer 2026 Nov 6. doi: 10.1007/s12282-026-01936.
PMID: 42993516